Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Curvebeam AI Ltd. ( (AU:CVB) ) has shared an announcement.
CurveBeam AI Limited has announced that its Annual General Meeting will be held on November 27, 2025, with the election of directors as a key agenda item. The closing date for director nominations is set for September 25, 2025. This announcement is part of the company’s compliance with ASX Listing Rule 3.13.1 and reflects its ongoing corporate governance processes.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited (ASX:CVB) is a company that develops, manufactures, and sells specialized medical imaging CT scanners, along with AI SaaS-based clinical assessment solutions. These products are designed to assist medical practitioners in managing musculoskeletal conditions. The company’s flagship product, HiRise™, offers both weight-bearing and traditional non-weight-bearing CT scans, providing distinct advantages over traditional CT or MRI devices. CurveBeam AI operates with over 70 employees, with its corporate office in Melbourne, Australia, and global operations headquarters in Hatfield, Pennsylvania, USA.
Average Trading Volume: 247,073
Technical Sentiment Signal: Hold
Current Market Cap: A$49.45M
Find detailed analytics on CVB stock on TipRanks’ Stock Analysis page.